AYR.A AYR WELLNESS INC

Ayr Wellness Introduces its National Portfolio of Brands to New Jersey Menus

Ayr Wellness Introduces its National Portfolio of Brands to New Jersey Menus

MIAMI, Oct. 20, 2022 (GLOBE NEWSWIRE) -- Ayr Wellness Inc. (CSE: AYR.A, OTCQX: AYRWF) (“Ayr'' or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator (“MSO”), announced the rollout of several brands from its national portfolio to the New Jersey market.

New Jersey cannabis consumers can now purchase products from brands including Lost in Translation (LIT) award-winning, premium whole flower; Kynd premium whole flower; Road Tripper whole flower; STIX pre-rolls; Entourage broad-spectrum, terpene-driven vape cartridges; Secret Orchard fruit-forward vape cartridges; and Wicked soft lozenges. All brands, with the exception of Kynd and Road Tripper, are currently available to both medical patients and adult-use consumers. Kynd and Road Tripper will debut on adult-use menus in the coming weeks.

“Since acquiring Garden State Dispensary, it has been Ayr’s mission to provide an elevated experience for all New Jersey patients and consumers. The introduction of our portfolio of high-quality brands to our menus marks a major milestone in carrying out that mission,” said Jonathan Sandelman, Founder and CEO of Ayr Wellness. “We know that our customers have diverse wants and needs, and it’s important to us that we meet them wherever they are in their cannabis journey.”

The portfolio of brands is available at Ayr’s retail stores, operating as Garden State Dispensary, which are in prime locations throughout New Jersey, in the towns of Woodbridge, Union, and Eatontown, as well as in 3rd party dispensaries throughout the state.

For more information about Ayr Wellness, please visit .

Forward-Looking Statements

Certain information contained in this news release may be forward-looking statements within the meaning of applicable securities laws. Forward-looking statements are often, but not always, identified by the use of words such as “target”, “expect”, “anticipate”, “believe”, “foresee”, “could”, “would”, “estimate”, “goal”, “outlook”, “intend”, “plan”, “seek”, “will”, “may”, “tracking”, “pacing” and “should” and similar expressions or words suggesting future outcomes. This news release includes forward-looking information and statements pertaining to, among other things, Ayr’s future growth plans. Numerous risks and uncertainties could cause the actual events and results to differ materially from the estimates, beliefs and assumptions expressed or implied in the forward-looking statements, including, but not limited to: anticipated strategic, operational and competitive benefits may not be realized; events or series of events, including in connection with COVID-19, may cause business interruptions; required regulatory approvals may not be obtained in a timely manner or at all; inflationary pressures may increase input costs; supply chain issues may hamper production and distribution; scientific research regarding cannabis is still in its early stages and is subject to change as further research is completed; state laws may restrict or prevent inter-state commerce in cannabis products; acquisitions may not be able to be completed on satisfactory terms or at all; and Ayr may not be able to raise needed additional debt or equity capital. Among other things, Ayr has assumed that its businesses will operate as anticipated, that it will be able to complete acquisitions on reasonable terms, and that all required regulatory approvals will be obtained on satisfactory terms and within expected time frames. Forward-looking estimates and assumptions involve known and unknown risks and uncertainties that may cause actual results to differ materially. While Ayr believes there is a reasonable basis for these assumptions, such estimates may not be met. These estimates represent forward-looking information. Actual results may vary and differ materially from the estimates.

About Ayr Wellness Inc.

Ayr is an expanding vertically integrated, U.S. multi-state cannabis operator. Based on the belief that everything starts with the quality of the plant, the Company’s mission is to cultivate the finest quality cannabis at scale and deliver remarkable experiences to its customers every day.

Ayr’s leadership team brings proven expertise in growing successful businesses through disciplined operational and financial management, and is committed to driving positive impact for customers, employees and the communities they serve. For more information, please visit .

Company/Media Contact:

Robert Vanisko

VP, Corporate Communications

Email:

Investor Relations Contact:

Sean Mansouri, CFA

Elevate IR

T: (720) 330-2829

Email:



EN
20/10/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on AYR WELLNESS INC

 PRESS RELEASE

AYR Wellness to Initiate CCAA Proceedings

AYR Wellness to Initiate CCAA Proceedings MIAMI, Nov. 17, 2025 (GLOBE NEWSWIRE) -- (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces the initiation of proceedings under the Companies’ Creditors Arrangement Act (Canada) (“CCAA”) in the Supreme Court of British Columbia. The CCAA proceedings are part of the Company’s restructuring process pursuant to the previously disclosed Restructuring Support Agreement dated July 30, 2025 (the “RSA”). Under the RSA, core assets of AYR’s subsidiaries will be transitioned to...

 PRESS RELEASE

AYR Wellness Announces Result of Article 9 Public Auction, Initiation ...

AYR Wellness Announces Result of Article 9 Public Auction, Initiation of Sale of Core Assets to its Senior Lenders MIAMI, Nov. 11, 2025 (GLOBE NEWSWIRE) -- (CSE: AYR.A, OTCQX: AYRWF) (“AYR”) together with its affiliates and subsidiaries (collectively, the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces that the public foreclosure auction (the “Sale”) contemplated by the Restructuring Support Agreement dated July 30, 2025 (the “RSA”), resulted in the credit bid submitted by the Company’s senior noteholders (the “Senior Noteholders”) being deemed t...

 PRESS RELEASE

AYR Wellness Launches Flower from its First Indoor Cultivation Facilit...

AYR Wellness Launches Flower from its First Indoor Cultivation Facility in Florida, Expanding Product Quality and Variety Registered patients can now obtain new Kynd brand flower offerings at AYR Wellness dispensaries statewide MIAMI, Oct. 14, 2025 (GLOBE NEWSWIRE) -- (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, announces the opening of its first-ever indoor cultivation facility in Florida, marking a major milestone for the Company and its customers in the Sunshine State. The new 97,580 sq. ft. facility featur...

 PRESS RELEASE

AYR Wellness Announces Commencement of Restructuring Support Agreement...

AYR Wellness Announces Commencement of Restructuring Support Agreement Article 9 Proceedings MIAMI, Oct. 13, 2025 (GLOBE NEWSWIRE) -- (CSE: AYR.A, OTCQX: AYRWF) (“AYR”) together with its affiliates and subsidiaries (collectively, the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, today announces the next step of its debt restructuring process with its senior noteholders. As contemplated by the Restructuring Support Agreement dated July 30, 2025 (the “RSA”), this next phase of the restructuring will be implemented through a foreclosure sale, conducted by ...

 PRESS RELEASE

AYR Wellness Announces Filing of Q1 2025 Interim Financial Statements ...

AYR Wellness Announces Filing of Q1 2025 Interim Financial Statements and MD&A MIAMI, Sept. 12, 2025 (GLOBE NEWSWIRE) -- (CSE: AYR.A, OTCQX: AYRWF) (“AYR” or the “Company”), a leading vertically integrated U.S. multi-state cannabis operator, today announces that it has filed its unaudited interim condensed consolidated financial statements for the three months ended March 31, 2025, together with the related Management’s Discussion and Analysis (“MD&A”).‎ The Q1 2025 interim financial statements and MD&A are now available for review under the Company’s profile on SEDAR+ at and on the U....

ResearchPool Subscriptions

Get the most out of your insights

Get in touch